Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.
Cancer Immunol Immunother
; 71(2): 433-444, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-34218294
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Azacitidine
/
Myelodysplastic Syndromes
/
Cancer Vaccines
/
Epigenesis, Genetic
/
Antigens, Neoplasm
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2022
Type:
Article
Affiliation country:
Denmark